Related Experiment Video
Updated: Jun 25, 2026
11:13
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
17beta-hydroxysteroid dehydrogenases in human breast cancer
Shuji Nagasaki1, Yasuhiro Miki, Jun-ichi Akahira
1Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Annals of the New York Academy of Sciences
|March 3, 2009
Summary
17beta-hydroxysteroid dehydrogenases (17beta-HSDs) are key enzymes in converting adrenal androgens to estrogen, fueling breast cancer growth. Understanding their roles is crucial for developing targeted therapies to inhibit local estrogen synthesis in breast cancer.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Estrogen is critical for breast carcinoma development and progression.
- Post-menopause, estrogen production shifts from ovaries to peripheral conversion of adrenal androgens.
- Enzymes like aromatase, steroid sulfatase, and 17beta-hydroxysteroid dehydrogenases (17beta-HSDs) mediate this conversion.
Purpose of the Study:
- To review the roles of 17beta-HSD isozymes in human breast carcinoma.
- To enhance understanding of estradiol biosynthesis mechanisms in breast cancer.
- To inform the development of targeted therapeutic agents for local estrogen synthesis inhibition.
Main Methods:
- Literature review of studies on 17beta-HSDs in human breast carcinoma.
- Analysis of the involvement of 17beta-HSD isozymes in estradiol biosynthesis.
- Examination of the relationship between 17beta-HSD expression and breast cancer progression.
Main Results:
- 14 isozymes of 17beta-HSD have been identified.
- The relative expression levels of 17beta-HSD isozymes are crucial for supplying estradiol to estrogen receptor-positive carcinoma cells.
- 17beta-HSDs are involved in the final steps of estradiol biosynthesis.
Conclusions:
- 17beta-HSDs play a pivotal role in human breast carcinoma by regulating local estradiol synthesis.
- Understanding 17beta-HSD isozyme characteristics is vital for developing targeted therapies.
- Further research into 17beta-HSDs can lead to novel treatment strategies for breast cancer.
